SCM
NTUS

SG Capital Management’s Natus Medical Inc NTUS Stock Holding History

SG Capital Management’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-66,701
Closed -$1.14M – 102
2020
Q3 		$1.14M Buy
+66,701
New +$1.26M 0.33% 59
2016
Q3 		– Sell
-468,518
Closed -$17.7M – 90
2016
Q2 		$17.7M Buy
468,518
+220,097
+89% +$7.37M 4.35% 4
2016
Q1 		$9.55M Buy
+248,421
New +$9.25M 2.67% 14

Other funds holding NTUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SG Capital Management's NTUS Position: Q4 2020 in Review

SG Capital Management sold out of Natus Medical Inc (NTUS) in Q4 2020, closing a stake of 66,701 shares — an estimated $1.14M sold.

SG Capital Management first reported a position in NTUS in Q1 2016 and held it in 3 quarters. The position peaked at $17.7M in Q2 2016. 163 funds tracked by Wall St. Rank hold NTUS as of Q4 2020.

  • SG Capital Management reported no remaining Natus Medical Inc position as of Q4 2020 after selling out during the quarter.
  • SG Capital Management sold 66,701 Natus Medical Inc shares in Q4 2020, an estimated $1.14M.
  • SG Capital Management first reported a position in Natus Medical Inc in Q1 2016 and held it in 3 quarters.
  • SG Capital Management's Natus Medical Inc position peaked at $17.7M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2020.

Based on SG Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.